Silo Pharma Financials
| SILO Stock | USD 1.96 0.02 1.01% |
With this module, you can analyze Silo financials for your investing period. You should be able to track the changes in Silo Pharma individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Silo |
The data published in Silo Pharma's official financial statements typically reflect Silo Pharma's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Silo Pharma's quantitative information. For example, before you start analyzing numbers published by Silo accountants, it's essential to understand Silo Pharma's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Silo Pharma Stock Summary
Silo Pharma competes with Rezolute, Anebulo Pharmaceuticals, Sino Biopharmaceutica, Inventiva, and Biocardia. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. Silo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| CUSIP | 82711P201 91670U101 82711P102 |
| Location | New Jersey; U.S.A |
| Business Address | 560 Sylvan Avenue, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | silopharma.com |
| Phone | 718 400 9031 |
| Currency | USD - US Dollar |
Silo Pharma Key Financial Ratios
Silo Pharma's financial ratios allow both analysts and investors to convert raw data from Silo Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Silo Pharma over time and compare it to other companies across industries.| Return On Equity | -0.44 | ||||
| Return On Asset | -0.25 | ||||
| Target Price | 10.0 | ||||
| Beta | 1.35 |
Silo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Silo Pharma's current stock value. Our valuation model uses many indicators to compare Silo Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Silo Pharma competition to find correlations between indicators driving Silo Pharma's intrinsic value. More Info.Silo Pharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Silo Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Silo Pharma's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Silo Pharma Systematic Risk
Silo Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Silo Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Silo Pharma correlated with the market. If Beta is less than 0 Silo Pharma generally moves in the opposite direction as compared to the market. If Silo Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Silo Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Silo Pharma is generally in the same direction as the market. If Beta > 1 Silo Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Silo Pharma Thematic Clasifications
Silo Pharma is part of Apparel investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Apparel industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Apparel industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Apparel | View |
Silo Pharma January 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Silo Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Silo Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Silo Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Silo OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Silo Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.98 | |||
| Information Ratio | 0.1469 | |||
| Maximum Drawdown | 59.71 | |||
| Value At Risk | (8.70) | |||
| Potential Upside | 10.89 |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.